Characterization of Fecal Microbiota in a Population Aged 50 to 75 Years Targeted by Seasonal Vaccination

NCT05972590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-19

No results posted yet for this study

Summary

The goal of this interventional study is to constitute a biological samples collection collected from healthy elderly volunteers and used for scientific purposes.

The main questions it aims to answer are:

* Improving knowledge of the composition of the gut microbiota
* Identify, isolate and culture microbiota species of interest in the field of health ageing or used as therapeutics associated to the vaccination
* Determining the correlation between the gut microbiota composition and the immune response of individuals.

Conditions

  • Elderly Volunteers

Interventions

OTHER

Biological samples collection (blood + feces)

Blood + stools samples will be collected from each volunteer

Sponsors & Collaborators

  • BioFortis

    collaborator OTHER
  • Bioaster

    lead OTHER

Principal Investigators

  • Cyril GUYARD · Bioaster

  • Stéphanie CAVIGIOLI · BioFortis

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-25
Primary Completion
2023-12-15
Completion
2023-12-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05972590 on ClinicalTrials.gov